EXHIBIT 10.03

 

SECOND AMENDMENT TO WORKERS’ COMPENSATION RECEIVABLES FUNDING, ASSIGNMENT AND
SECURITY AGREEMENT (CA)

 

THIS SECOND AMENDMENT (this “Amendment 2”) to the Workers’ Compensation
Receivables Funding, Assignment and Security Agreement (CA), dated June 27, 2013
(the “Agreement”) and to the First Amendment to Workers’ Compensation
Receivables Funding, Assignment and Security Agreement dated September 30, 2013
(“Amendment”), by and between CAMBRIDGE MEDICAL FUNDING GROUP LLC a Delaware
limited liability company (together with its successors and permitted assigns,
“CMFG”), and TARGETED MEDICAL PHARMA, INC., a Delaware corporation (together
with its successors and permitted assigns, “TMP”), is made and entered into this
23rd day of October 2013.

 

For good and valuable consideration, the receipt and sufficiency of which are
hereby acknowledged, CMFG and TMP (each of which may be individually referred to
herein as a “Party” or, collectively, as “the Parties” and/or “Parties”), hereby
agree as follows:

 

1.         Updates to Agreement and Amendment. The Parties hereby agree that the
Agreement and Amendment shall be amended as follows:          

 

(a)         Section 2.1 of the Amendment to the Agreement (Funding Amount) is
hereby amended to read as follows:

 

“2.1         Funding Amount. In consideration for assignment of TMP’s rights in
such Funded Receivables and the proceeds thereof now existing or hereafter
arising to CMFG as provided in this Agreement, CMFG shall fund to TMP a sum of
$3,200,000 (the “Funding Amount”). CMFG shall provide TMP with funding of
$750,000 on or prior to June 30, 2013 with the balance of $2,450,000 to follow
thereafter to TMP by September 30, 2013. A Closing Fee equal to 3% of the
Funding Amount shall be deducted from the proceeds of the Funding Amount and
retained by CMFG.”

 

(b)         Section 2.5 of the Amendment to the Agreement (Transfer of Rights in
Funded Receivables) is hereby amended to read as follows:

 

“2.5         Transfer of Rights in Funded Receivables. Other than the payments
set forth in Section 2.6 of this Agreement, TMP acknowledges and agrees that,
any and all legal and equitable right, title and interest TMP may have had, has
or will at any time have in the Funded Receivables are hereby forever
transferred and assigned to CMFG (to the extent permitted by applicable law).
TMP will not retain any right whatsoever to recover any payments from insurers,
or from the proceeds of any settlement or judgment recovered by, or behalf of WC
patients by their attorneys or otherwise arising out of, in connection with, or
related to Funded Receivables, other than as set forth herein. TMP agrees to
immediately remit any such payment it may receive relating to the Funded
Receivables and proceeds thereof to CMFG and to provide unlimited access to
accounting, reporting and database systems related to the Funded Receivables and
proceeds thereof. CMFG’s interest in the Funded Receivables (and the proceeds
thereof) and all TMP Obligations shall be secured by a first priority lien on
and perfected security interest in all Funded Receivables, to the extent
permitted by applicable law, and the proceeds of all Funded Receivables (which
the parties herein agree that their estimated face value is forty-two million
dollars ($42,000,000)), and by a first priority lien on and perfected security
interest in all Non-Workers’ Compensation Receivables, to the extent permitted
by applicable law, and the proceeds thereof, as more specifically set forth
hereinafter. The lien on the Non-Workers’ Compensation Receivables shall be
released upon CMFG’s receipt of $3,654,000.00 from collections of Funded
Receivables. At all times up until CMFG has received $3,654,000.00 from
collections of Funded Receivables, TMP represents, warrants and agrees that it
shall maintain a reserve of Non-Workers’ Compensation Receivables with a face
value of not less than twenty million dollar ($20,000,000.00) to secure the TMP
Obligations. Upon the request from time to time of CMFG, TMP will deliver
evidence to CMFG that it has so maintained such reserves of Non-Workers
Compensation Receivables.

 

 

 

 

(c)         Section 2.5 A. of the Amendment to the Agreement (Transfer of Rights
in Funded Receivables) is hereby amended to read as follows:

  

Third, until such time as CMFG shall have been paid an aggregate amount of
$3,200,000 from collections of Funded Receivables (for the avoidance of doubt,
excluding any Servicing Fees, Reimbursable Expenses, and servicing expenses paid
to CMFG), to CMFG, in the amount of up to $175,000 per month in respect of
collections related to Funded Receivables (the “CMFG Monthly Amount”). To the
extent that the CMFG Monthly Amount paid to CMFG pursuant to this clause Third
is less than $175,000 in any month, TMP shall pay to CMFG the aggregate amount
of such shortfall (each such payment, a “Monthly Shortfall Payment”), within
five (5) business days after the end of such month;

 

Fourth, until such time as CMFG shall have been paid an aggregate amount of
$3,200,000 from collections of Funded Receivables (for the avoidance of doubt,
excluding any Servicing Fees, Reimbursable Expenses, and servicing expenses paid
to CMFG), to TMP, in the amount of up to $125,000 per month in respect of
collections related to Funded Receivables (the “TMP Monthly Amount”);

 

2

 

 

Fifth, until such time as CMFG shall have been paid an aggregate amount of
$3,200,000 from collections of Funded Receivables (for the avoidance of doubt,
excluding any Servicing Fees, Reimbursable Expenses, and servicing expenses paid
to CMFG), 50% to CMFG and 50% to TMP; and

 

Sixth, from and after such time as CMFG shall have been paid an aggregate amount
of $3,200,000 from collections of Funded Receivables (for the avoidance of
doubt, excluding any Servicing Fees, Reimbursable Expenses, and servicing
expenses paid to CMFG), 45% to CMFG and 55% to TMP. CMFG shall cause the first
$80,000 due CMFG under this Sixth clause to be paid to CMFG’s investors pursuant
to the Participation Agreement, dated September 30, 2013, between the
Participants and CMFG.

  

         (d)         Section 5 of the Amendment to the Agreement (Security
Interest) is hereby amended to read as follows:

 

“5.         SECURITY INTEREST.

         

       To secure the due payment and performance of the TMP Obligations, TMP
hereby grants to CMFG a continuing first priority lien on and security interest
in all of its right, title, and interest in and to the following property,
whether now existing or hereafter arising: (a) to the extent permitted by
applicable law, any and all Funded Receivables; (b) any and all proceeds of and
amounts and other property received or receivable in respect of Funded
Receivables, in whatever form, including, without limitation, all cash, money,
instruments, collections, and other amounts arising out of or in connection with
any Funded Receivables, any deposit accounts into which any such proceeds and
amounts are deposited, and all proceeds of the forgoing; (c) to the extent
permitted by applicable law, any and all Non-Workers’ Compensation Receivables;
and (d) any and all proceeds of and amounts and other property received or
receivable in respect of Non-Workers’ Compensation Receivables, in whatever
form, including, without limitation, all cash, money, instruments, collections,
and other amounts arising out of or in connection with any Non-Workers’
Compensation Receivables, any deposit accounts into which any such proceeds and
amounts are deposited, and all proceeds of the forgoing. CMFG’s lien on and
security interest in the Non-Workers’ Compensation Receivables shall be released
upon payment to CMFG of $3,654,000.00 in good funds from collections of Funded
Receivables. At all times up until CMFG has been paid $3,654,000.00 in good
funds from collections of Funded Receivables, TMP shall maintain a reserve of
Non-Workers’ Compensation Receivables in an amount of not less than Twenty
Million Dollar ($20,000,000.00) to secure the TMP Obligations.”

 

3

 

 

         (e)         Section 6.2 of the Amendment to the Agreement (No Other
Lien) is hereby amended to read as follows:

 

“6.2         No Other Lien. TMP further promises, covenants and agrees that it
has not, and shall not grant or otherwise permit, cause or suffer the existence
of any other security interest, pledge, lien or encumbrance in favor of another
party (other than CMFG) on, or transfer any interest in (other than to CMFG),
any of the following assets of TMP: any of the Funded Receivables assigned by
TMP to CMFG, any of the Non-Workers’ Compensation Receivables, any proceeds of
any of the foregoing, any cash, any money, any deposit account, and any other
asset upon which CMFG has been granted a lien; provided, however, that this
Section 6.2 shall not apply to any of the Non-Workers’ Compensation Receivables
beginning at such time as CMFG has been paid $3,654,000.00 in good funds from
collections of Funded Receivables.”

    

[Signature Page Follows]

 

4

 

 

IN WITNESS WEREOF, the parties have executed this Amendment as of the 23rd day
of October 2013.

 

Witnessed and/or Attested to by:   TARGETED MEDICAL PHARMA, INC.      
___________________________________   ___________________________________    
By:  David Silver, MD     Title:                   CAMBRIDGE MEDICAL FUNDING
GROUP LLC       ___________________________________  
___________________________________     By:  Cy E. Hammond     Chief Financial
Officer and Vice President of Operations